• OPEN AN ACCOUNT
Indian Indices
Nifty
25,405.30 -48.10
(-0.19%)
Sensex
83,239.47 -170.22
( -0.20%)
Bank Nifty
56,791.95 -207.25
( -0.36%)
Nifty IT
38,854.30 -24.80
( -0.06%)
Global Indices
Nasdaq
44,498.76 -17.19
(-0.04%)
Dow Jones
6,247.07 28.06
(0.45%)
Hang Seng
39,705.85 -56.63
(-0.14%)
Nikkei 225
8,823.20 48.51
(0.55%)
Forex
USD-INR
85.59 -0.04
(-0.04%)
EUR-INR
100.92 0.38
(0.38%)
GBP-INR
117.62 0.20
(0.17%)
JPY-INR
0.60 0.00
(0.46%)

EQUITY - MARKET SCREENER

Pharmaids Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524572
INE117D01018
18.0866939
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
201.03
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

looks health services ltd
Radhagobind Commercial reports standalone net loss of Rs 0.10 crore in the March 2025 quarter
Jun 01,2025
Net Loss of Radhagobind Commercial reported to Rs 0.10 crore in the quarter ended March 2025 as against net loss of Rs 0.21 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.39 crore in the year ended March 2025 as against net loss of Rs 7.51 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.